SUTAB
Active substance: SODIUM SULFATE, MAGNESIUM SULFATE ANHYDROUS, POTASSIUM CHLORIDE
TABLET · SODIUM SULFATE 17.75 g/1, MAGNESIUM SULFATE ANHYDROUS 2.7 g/1, POTASSIUM CHLORIDE 2.25 g/1
United StatesActive
Marketing holder: Azurity Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM SULFATE · 17.75 g/1
- MAGNESIUM SULFATE ANHYDROUS · 2.7 g/1
- POTASSIUM CHLORIDE · 2.25 g/1
Registration
- Registration number
- 24338-201
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 24338-201 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 24338-201 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 24338-201 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 24338-201 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 24338-201 · Verified 2026-10-09 · open in source